-
-
-
-
-
-
-
22nd Century Group Reports First Quarter 2025 Financial Results
-
-
-
-
-
-
-
22nd Century Group's (XXII) Senior Lender Approves Sale of Hemp/Cannabis Franchise on Improved Terms
-
-
-
-
-
-
-
22nd Century Group (XXII) Reports Q1 Revenue of $22M, Net Loss of $18.2M; Guides FY23 Revenue of $105-$110M
-
-
-
-
-
-
-
22nd Century Group (XXII) Reports Q3 Revenue of $19.4M, Net Loss of $13.1M
-
-
-
-
-
-
-
22nd Century Group (XXII) Acquires GVB Biopharma
-
-
-
-
-
-
-
Pre-Open 08/29: (ROX) (NTNX) (GES) Higher (OLLI) (ANF) (BOX) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Movers 05/01: (OCN) (XXII) (TWTR) Higher; (FNBC) (AEZS) (ITCI) Lower (more...)
-
1,185,334 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

